Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 2:13:1029137.
doi: 10.3389/fendo.2022.1029137. eCollection 2022.

A review of the genetics and epigenetics of central precocious puberty

Affiliations
Review

A review of the genetics and epigenetics of central precocious puberty

Joshua Moise-Silverman et al. Front Endocrinol (Lausanne). .

Abstract

Gonadotrophin dependent sexual precocity, commonly referred to as central precocious puberty (CPP), results from a premature reactivation of the hypothalamic-pituitary-gonadal (HPG) axis before the normal age of pubertal onset. CPP is historically described as girls who enter puberty before the age of eight, and boys before the age of nine. Females are more likely to be diagnosed with idiopathic CPP; males diagnosed with CPP have a greater likelihood of a defined etiology. These etiologies may include underlying CNS congenital defects, tumors, trauma, or infections as well as environmental, genetic, and epigenetic factors. Recently, genetic variants and mutations which may cause CPP have been identified at both the level of the hypothalamus and the pituitary. Single nucleotide polymorphisms (SNPs), monogenetic mutations, and modifications of the epigenome have been evaluated in relationship to the onset of puberty; these variants are thought to affect the development, structure and function of GnRH neurons which may lead to either precocious, delayed, or absent pubertal reactivation. This review will describe recent advances in the field of the genetic basis of puberty and provide a clinically relevant approach to better understand these varying etiologies of CPP.

Keywords: GnRH; central precious puberty; epigenetic; genetics; kisspeptin.

PubMed Disclaimer

Conflict of interest statement

Author LS is a consultant to ENDO Pharma, Tolmar Pharmaceuticals, Enteris BioPharma, Myovant Sciences. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Location of expression of genes associated with CPP.

References

    1. Latronico AC, Brito VN, Carel JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol (2016) 4(3):265–74. doi: 10.1016/S2213-8587(15)00380-0 - DOI - PubMed
    1. Berberoğlu M. Precocious puberty and normal variant puberty: Definition, etiology, diagnosis and current management. J Clin Res Pediatr Endocrinol (2009) 1(4):164–74. doi: 10.4274/jcrpe.v1i4.3 - DOI - PMC - PubMed
    1. Gangat M, Radovick S. Precocious puberty. Minerva Pediatr (2020) 72(6):491–500. doi: 10.23736/S0026-4946.20.05970-8 - DOI - PubMed
    1. Williams R. Williams textbook of endocrinology. 13th edition. Melmed S, Polonsky KS, Larsen PR, Kronenberg H, editors. Philadelphia, PA: Elsevier; (2016). 1916 p.
    1. Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, Weiner RI. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron (1990) 5(1):1–10. doi: 10.1016/0896-6273(90)90028-e - DOI - PubMed

Substances

LinkOut - more resources